A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)
Clinical trial NCT03263715 · COMPLETED
Trial details
- NCT number
- NCT03263715
- Sponsor
- Medical University of Vienna
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-24
- Primary completion
- 2020-06-02
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.